SEC Form 3 · accession 0001209191-15-026663
Kura Oncology, Inc. · KURA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yi Liu
Officer — Chief Scientific Officer
Period of report
Mar 6, 2015
Accepted (ET)
Mar 16, 2015 · 7:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | holding | — | — | — | 734,375 | D | ||
| Common stock | holding | — | — | — | 7,812 | I | Custodian for Max Liu | |
| Common stock | holding | — | — | — | 7,812 | I | Custodian for Nicholas Liu |
Table II — derivative securities
No Table II lines on this filing.